Very Low Ketogenic Diet and Energy Expenditure
- Conditions
- Energy Metabolism
- Interventions
- Dietary Supplement: very low ketogenic diet
- Registration Number
- NCT06252077
- Lead Sponsor
- University of Pisa
- Brief Summary
This study aimed at evaluating the effectiveness of the active phase of a very low-calorie ketogenic diet in females with obesity lasting 28 days on body weight, body composition and energy metabolism using a metabolic chamber.
- Detailed Description
Patients were recruited at the Obesity and Lipodystrophy Center, University Hospital of Pisa. Enrolled subjects underwent active phase of very low-calorie ketogenic diet within the metabolic chamber from day 0 for a duration of 4 weeks (day 0-28). On days 0, 7, and 28, patients underwent a 24-hour measurement of energy metabolism using the metabolic chamber. On the day of exit from the chamber measurement of body composition was conducted using total-body densitometry (Lunar iDXA; GE Healthcare).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
- overweight and obesity
- Type 1 and type 2 diabetes mellitus
- endocrine disorders
- asthma or pulmonary conditions
- cardiovascular disease
- gastrointestinal disease
- liver disease
- kidney diseases
- anemia (hemoglobin < 11 g/dL)
- leucopenia (white blood cells < 4,000/mcL)
- thrombocytopenia (platelets < 150,000/mcL)
- central nervous system disorders
- neurodegenerative diseases
- psychiatric disorders
- eating disorders
- alcohol abuse and substance dependence
- pregnancy
- lactation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description very low ketogenic diet very low ketogenic diet patients with overweight and obesity in treatment for weight loss
- Primary Outcome Measures
Name Time Method measure of energy expenditure 1 month measures of energy expenditure (in kilocalories) will be assessed by using the metabolic chamber, 24-hour whole room indirect calorimeter. Thus, the measures will be expressed in Kilocalories over 24 hours.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital of Pisa, Endocrinology Unit
🇮🇹Pisa, Italy